IN FOCUS
THE INDEPENDENT YEARS · SR ONE SPUN OUT FROM GSK IN 2020 · SIMEON GEORGE: INVESTOR & FOUNDER

THE FOUNDER’S SIDE OF THE TABLEPERSON / VENTURE CAPITAL / SAN FRANCISCO

Simeon George and the business of making your own luck

He joined SR One in 2007, helped start companies, and then helped turn his own investment firm into a startup. Simeon George’s career is a study in what happens when an investor takes the founder’s side of the table.

Simeon George had spent years helping other people start companies when he helped give his own firm an independent life. In November 2020, SR One announced its separation from GSK and a $500 million first independent fund. George had joined the organization in 2007. The investor was now also a co-founder of the business doing the investing.

That is a pleasing complication in a profession often described through checks, stakes and exits. An investment firm has its own founding problem: someone must persuade people that this team, with this judgment, deserves their capital. George’s career brings that responsibility into view. He has occupied both seats at the table, sometimes without changing the table.

His public biography offers enough institutions to furnish a respectable alphabet soup: Johns Hopkins, Penn, Wharton, Goldman Sachs, Bain, GSK. Yet the revealing part is the movement between them. The credentials establish preparation. The choices show a growing interest in assembling organizations around ideas - and accepting the obligations that follow.

An education with several doors open

George holds a BA from Johns Hopkins University and an MD and MBA from the University of Pennsylvania School of Medicine and the Wharton School. His earlier professional life included investment banking at Goldman Sachs and management consulting at Bain & Company. These were different entrances into the work he would eventually do at SR One.

Banking, consulting and company building put different questions in front of a person. What is an opportunity worth? How does an organization work? Who can carry an idea into a business? George’s path runs through all three. It is tempting to treat the degrees and employers as a plan unfolding neatly. A career is usually messier than its biography.

By 2007, he had joined SR One, then GSK’s corporate venture operation. The distinction matters. He entered an existing institution, with an existing owner, rather than raising a fund under his own name. His later independence would grow out of work already done inside that institution. The corporate years were part of the preparation.

THREE TURNS IN ONE CAREER
  1. 2007Joins SR One
  2. 2018Becomes CEO
  3. 2020Co-founds the independent firm
From an established corporate venture operation to an independent business.

A first lesson in the price of patience

The calendar was unhelpful. George’s arrival preceded the global financial crisis, and the years that followed became part of his investing education. He has described that period as formative. Money was constrained; the work required attention to fundamentals and capital efficiency. An apprenticeship in those conditions comes with fewer opportunities to confuse a rising market with personal brilliance.

Years later, discussing another difficult market, he returned to the discipline of those early years. The continuity is interesting. Markets change their mood more readily than people change the lessons they learned when something was hard. A founder may prefer an encouraging audience, but a business still needs enough resources to keep working when the audience becomes distracted.

George’s account of the independent firm includes planning for detours and maintaining reserves. There is an ordinary practicality beneath the venture vocabulary: leave room for things to take longer. The spreadsheet may offer an orderly sequence. The people responsible for the sequence have to live through interruptions. His compact formulation is worth keeping: “No story is linear.”

“No story is linear.”

Simeon George

Before the fund, the blank page

George’s record includes co-founding Nkarta and Arcellx, as well as leading investments in CRISPR Therapeutics, Principia Biopharma, Turning Point Therapeutics and Progyny. The names mark two forms of participation. Some companies he helped back; others he helped start. Both require a view of the future, but the founder must also help assemble the present.

He has described the starting point for Arcellx and Nkarta as a “blank sheet of paper.” The image is useful because it leaves the organization visible by its absence. Before the company has departments and a calendar full of meetings, people have to agree that the proposed work is worth doing together. A blank sheet can be wonderfully economical. It employs nobody.

The entrepreneurial experience adds a different perspective to his investing career. The person evaluating a team has also had to help create one. That does not remove uncertainty from the next decision. It does make the questions less abstract: whom do you need, what can they contribute, and what would persuade them to commit?

The point is easy to lose in a list of investments. A portfolio compresses years of work into names. A founding story restores the awkward beginning, when the name belongs to an intention and the organization has to be recruited into existence. George’s biography contains both views, the finished list and the unfinished task.

Simeon George in a blue jacket and white shirt in a published press photograph
A different seat at the table. George in the press photograph accompanying his October 2023 interview.

Independence, with obligations attached

The 2020 spinout changed the structure around that work. SR One became an independent firm, with George as a co-founder and chief executive. Its first fund closed at $500 million, backed by GSK and a broader group of institutional and private investors. The announcement was a financial event and an organizational turning point.

An independent venture firm has more than one constituency to convince. It seeks commitments from investors while deciding where to make commitments of its own. That creates a useful symmetry in George’s story. The firm helping founders raise money must also make a case for its own future. Its judgment becomes part of what other people are buying.

The second independent fund, announced in March 2023, closed at over $600 million against a $500 million target. Its investors included endowments, foundations, pension funds, sovereign wealth funds, pharmaceutical companies and family offices. The range matters as much as the amount. Independence meant building a broader base for the organization.

The first two fund closings therefore offer a way to read the career without treating the amounts as personal trophies. They are commitments to a firm and its work. They say something about the scale of the responsibility George and his colleagues accepted. A large number can look reassuring in a headline; inside an organization it also represents expectations.

THE FIRST TWO INDEPENDENT FUNDS
2020$500 million
2023Over $600 million
Independent venture fund closings, shown separately. The 2023 bar uses $600 million as its minimum value; these are firm fund sizes.

The work after the introduction

George’s advice to aspiring entrepreneurs gives recruitment a central place: “You need to be able to recruit talent around you, and retain talent.” The second half deserves the space it takes. Persuading someone to join is one event. Giving that person reasons to keep doing difficult work alongside you is a continuing responsibility.

His discussions of investing return to conviction, preparation and the teams responsible for execution. He also encourages founders to engage with potential investors and remain open to feedback. Taken together, those ideas suggest a demanding social task. A founder has to make a clear case while remaining capable of hearing something inconvenient about it.

That combination makes company building more interesting than the usual celebration of confidence. Confidence can get a meeting started. It cannot do every job in the organization. Recruitment, retention and responsiveness each ask the founder to deal with other people as people, with expertise and judgment of their own. A business needs enough conviction to proceed and enough attention to learn.

SR One describes its method as backing and building. Its California and London teams give the work a transatlantic base. The geography widens the set of people and opportunities the firm can encounter. It also makes the organization a practical exercise in working across distance. An international footprint has to earn its keep in ordinary working relationships.

A wider world, a more exacting question

In May 2026, George described an investment environment becoming more international and more competitive. His phrasing was direct: “The ecosystem is more global and more competitive.” He connected that competition with a higher threshold for commitment and a preference for financing companies toward decisive milestones.

The position is consistent with the career’s earlier concerns about resources and execution. If competition increases, an attractive idea has to carry more weight. Investors need a clearer understanding of what the next commitment will allow a company to establish. For a founder, the question becomes concrete: what useful evidence will this money make possible?

George continued discussing the firm’s evolution in recorded conversations during 2026. A February BioHub appearance and a March BioVenture VoiCes interview revisited his path and SR One’s independence. In July, he joined Bloomberg Intelligence’s Sam Fazeli to discuss the investment outlook. The subjects have widened with the firm, while the history remains part of his explanation.

Leaving room for the unexpected

There is one small detail that keeps this story from becoming a triumphal procession of institutions and fund sizes. George likes the expression “luck surface area.” When asked about it, he made clear that he had encountered it elsewhere. He did not claim authorship. Even the slogan arrives with a modest acknowledgment of somebody else’s contribution.

As an image for a career, it has a certain charm. Preparation creates more possible encounters. Work puts a person in places where an opportunity might appear. Neither guarantees the result. The idea leaves room for effort and accident to share responsibility, which is more convincing than a biography in which every good outcome was inevitable.

George’s own sequence gives that thought substance: joining a corporate firm, investing through changing markets, helping found companies, then helping establish an independent investment business. Each step involved other people choosing to participate. The story’s scale comes from those accumulated commitments, as well as from the money attached to them.

The blank sheet and the fund announcement belong in the same account. One shows how little a company has at the beginning; the other shows what a group can eventually persuade others to commit. George has worked on both. The paper fills gradually, through decisions, colleagues and obligations. Even luck, in this version of the story, has people to meet.